Members directory | Become a member | My DCVMN

Contact us

News

April 10, 2024

DCVMN at the World Vaccine Congress Biodefence Pre-Workshop

CEO DCVMN Advocacy Pandemic Preparedness Vaccines & immunization

April 3, 2024

DCVMN CEO Engagements in Addis Ababa

Africa CEO DCVMN Advocacy developingcountries WeConnectToProtect

March 31, 2024

DCVMN CEO at the International Conference on Innovation, Intellectual Property, and Technology Transfer in Africa’s Pharmaceutical Sector

CEO Conference DCVMN Advocacy

March 18, 2024

DCVMN Chairing “Facilitating Technology Transfer to Promote Local Manufacturing and Access to Vaccines, Medicines, and Health Technologies in Sub-Saharan Africa” Conference

CEO Conference DCVMN Advocacy

March 14, 2024

DCVMN Joint Statement with IFPMA and Trade Associations on Biopharmaceutical Industry Commitments

DCVMN Advocacy developingcountries Statement WeConnectToProtect

December 15, 2023

Panacea Biotec launches EasyFourPol® in India and receives registration of Valganciclovir Powder for Oral Solution in Germany

Global Health Healthcare Milestones Vaccine Equity Vaccines & immunization Vacine Innovation WeConnectToProtect

November 28, 2023

The 2nd World Local Production Forum

November 28, 2023

Sustainable Action for Climate and Health

November 28, 2023

IIL launches measles, rubella vaccine for children

#VaccineAdvancements GlobalHealth SouthSouthPartnerships vaccinedevelopment

November 28, 2023

Two pharma cos set to begin 3rd phase of human trials for dengue vaccine

#VaccineAdvancements CollaborativeInnovation DCVMNpartnerships

September 3, 2023

Initiative Covid-19 Technology Access Pool (C-TAP)

COVID-19 DCVMN achievements Vaccines & immunization WHO

August 2, 2023

Global equity and timely access: COVID-19 & beyond 23rd DCVMN Annual General Meeting 2022 report

access DCVMN AGM developingcountries manufacturing sustainability vaccinedevelopment Vaccines

Our sponsors

Our sponsors

Our sponsors

Our sponsors